Pursuant to Regulation 30 of SEBI Listing Regulations, Board of Directors at its meeting held today i.e 10th August, 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) ....

Ref. No.: WOCK/SEC/SE/2026-27/030 10th August, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers Bandra Kurla Complex Dalal Street Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 532300 NSE Symbol: WOCKPHARMA Dear Sir/Madam, Subject: Outcome of the Board Meeting Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations’); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2026-27/027 dated 4th August, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 10th August, 2026, inter-alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026; Pursuant to Regulations 30 and 33 read with Schedule III of the Listing Regulations, we enclose herewith the Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026 along with the Limited Review Report issued by MSKC & Associates, LLP, Statutory Auditors of the Company on the same (enclosed as Annexure I) The meeting of the Board of Directors commenced at 1:10 p.m. and concluded at 3:05 p.m. Kindly take the same on record. Thanking you, For Wockhardt Limited Rashmi Mamtura Company Secretary Encl: as above ot y’.io- 'J_ /; it MSKC & Associates LLP 602, Floor 6, Raheja Titanium Western Express Highway, Geetanjali Railway Colony Chartered Accountants Ram Nagar, Goregaon (E) Mumbai 400063, INDIA Independent Auditor’s Review Report on standalone unaudited financial results of Wockhardt Limited for the quarter ended June 30, 2026 pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. To The Board of Directors of Wockhardt Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results of Wockhardt Limited (hereinafter referred to as ‘the Company’) for the quarter ended June 30, 2026 (‘the Statement’) attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Regulations’). 2. This Statement, which is the responsibility of the Company’s Management and has been approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’, prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) read with relevant rules issued thereunder (‘Ind AS 34’) and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of I he Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For M S K C 6 Associates LLP Chartered Accountants ICAI Firm Registration Number: 001595S/S000168 Bhavik L.Shah Partner Membership No,: 122071 UDIN: 261220710LXIBA4826 Place: Mumbai ■ Date: August 10, 2026 Registered Office: 10u' Floor, Level 13th, Module 4, 21/22, Olympia Cyberspace, Alandur Road, Arulaiyammanpet, Guindy, Chennai 600032, Tamil Nadu, India Id: 44 6131 0200 | LLPIN: ACK-7004 Ahmcdabad | Bengaluru | Chennai | Giirugram | Hyderabad | Kolkata | Pune WOCKHARDT LIMITED Registered Office: D-4 MIDC, Chikalthana, Chhatrapati Sambhaji Nagar - 431 006 Global Headquarters: Wockhardt Towers, Bandra ICurla Complex, Bandra (East), Mumbai 400 051 C1N:L24230MH1999PLC 120720 Tel: 91 22 2653 4444 ; Fax: 91 22 2652 3905; e-mail id : investorrelations@wockhardt.com; Website: www.wockhardt.com STATEMENT OF STANDALONE UNAUDITED RESULTS FOR THE QUARTER ENDED .It NIC 31). 21126 (Rs in Crore except per share data) PARTICULARS 3 MONTHS 3 MONTHS 3 MONTHS YEAR ENDED ENDED ENDED ENDED 30/06/2026 31/03/2026 30/06/2025 31/03/2026 (Refer notes below) Unaudited Audited Unaudited Audited (Refer note 2) 1 Income (a) Revenue from operations 561 516 413 1,739 (h) Other income 33 55 25 137 Total income 594 571 438 1,876 2 Expenses (a) Cost of materials consumed 106 79 74 309 (b) Purchase of stock-in-trade 57 40 39 198 (c) Changes in inventories of finished goods, stock-in-trade and work-in-progress 0.08 1 (0.05) (92) (d) Employee benefits expense 85 79 68 313 (e) Finance costs 4J 41 41 176 (f) Depreciation and amortisation expense 41 43 46 186 (g) Other expenses 155 156 101 494 Total expenses 487 439 369 1,584 3 Profit before exceptional items and tax (1-2) 107 132 69 292 4 Exceptional items- credit - 35 25 5 Profit before tax (3 ± 4) 107 167 69 317 6 Tax expense Current tax Deferred tax - * - - 7 Net Profit after tax (5 ± 6) 107 167 69 317 8 Other Comprehensive Income: i) Items that will not be reclassified to Profit or Loss - 0 08 1 (0.23) 0.08 credit/(charge) (consisting of re-measurement of net defined benefit liability) il) Income tax relating to items that will not be reclassified to - - - - Profit or Loss iii) Other Comprehensive Income (net of tax) (8i ± 8ii) 0.08 1 (0.23) 0.08 9 Total Comprehensive Income (7 ± 8(111)) 107 168 69 317 10 Paid-up equity share capital (face value of Rs 5/- each) 81 81 81 81 " Other Equity excluding Revaluation Reserves as per balance 3,003 sheet 12 Earnings per share (face value of Rs. 5/- each) (*not annualised) (a) Basic (Rs ) 6 62* 10.29* 4.25* 19.54 (b) Diluted (Rs) 6.61* 10.28* 4.25* 19.52 Notes to Standalone results 1) The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on August 10, 2026 The results have been subjected to limited review by the Statutory Auditors of the Company. 2) Figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures of the full financial year and the reviewed published figures upto the third quarter of the financial year 2025-26 3) The Company is exclusively into Pharmaceutical business segment. MSKC St Associates LLP 602, Floor 6, Raheja Titanium Western Express Highway, Geetanjali Railway Colony Chartered Accountants Ram Nagar, Goregaon (E) Mumbai 400063, INDIA Independent Auditor’s Review Report on consolidated unaudited financial results of Wockhardt Limited for the quarter ended June 30, 2026 pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Wockhardt Limited 1. We have reviewed the accompanying statement of consolidated unaudited financial results of Wockhardt Limited (hereinafter referred to as ‘the Company’ or ‘the [Showing first 8,000 characters — download PDF for full document]